Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Carbone

Showing results (441-450 of 651) with videos related to

Pageof 66
Sort By:
Journal of Medical Genetics|July 5, 2005
Cloned fusion product from a rare t(15;19)(q13.2;p13.1) inhibit S phase in vitroN Haruki, K S Kawaguchi, S Eichenberger, et al.
Cancer Research|August 22, 2015
Akt Kinase-Interacting Protein 1 Signals through CREB to Drive Diffuse Malignant MesotheliomaTadaaki Yamada, Joseph M Amann, Koji Fukuda, et al.
Oncogene|June 30, 2015
LKB1 deficiency enhances sensitivity to energetic stress induced by erlotinib treatment in non-small-cell lung cancer (NSCLC) cellsY M Whang, S I Park, I A Trenary, et al.
Lung Cancer (Amsterdam, Netherlands)|March 26, 2020
Prognostic value and therapeutic implications of expanded molecular testing for resected early stage lung adenocarcinomaPeter J Kneuertz, David P Carbone, Desmond M D'Souza, et al.
Lung Cancer (Amsterdam, Netherlands)|April 5, 2016
Epidermal growth factor receptor (EGFR) mutations in small cell lung cancers: Two cases and a review of the literatureBradford J Siegele, Konstantin Shilo, Bo H Chao, et al.
JTO Clinical and Research Reports|October 14, 2021
Comparison of Tumor Microenvironments Between Primary Tumors and Brain Metastases in Patients With NSCLCDaiki Ikarashi, Tamio Okimoto, Takehito Shukuya, et al.
Cancer Research|September 18, 2004
Combination therapy with conditionally replicating adenovirus and replication defective adenovirusChoon-Taek Lee, Kyung-Ho Park, Kiyoshi Yanagisawa, et al.
Lung Cancer (Amsterdam, Netherlands)|October 27, 2019
Cost-effectiveness analysis of pembrolizumab versus chemotherapy as first-line treatment in locally advanced or metastatic non-small cell lung cancer with PD-L1 tumor proportion score 1% or greaterLongjiang She, Huabin Hu, Mengting Liao, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 13, 2001
Phase I chemoprevention study of difluoromethylornithine in subjects with organ transplantsP P Carbone, J D Pirsch, J P Thomas, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 28, 2017
Prognostic Value of Primary Tumor Volume Changes on kV-CBCT during Definitive Chemoradiotherapy for Stage III Non-Small Cell Lung CancerPatrick Wald, Xiaokui Mo, Christian Barney, et al.
Pageof 66

Showing results (441-450 of 651) with videos related to

Sort By:
Pageof 66
Journal of Medical Genetics|July 5, 2005
Cloned fusion product from a rare t(15;19)(q13.2;p13.1) inhibit S phase in vitroN Haruki, K S Kawaguchi, S Eichenberger, et al.
Cancer Research|August 22, 2015
Akt Kinase-Interacting Protein 1 Signals through CREB to Drive Diffuse Malignant MesotheliomaTadaaki Yamada, Joseph M Amann, Koji Fukuda, et al.
Oncogene|June 30, 2015
LKB1 deficiency enhances sensitivity to energetic stress induced by erlotinib treatment in non-small-cell lung cancer (NSCLC) cellsY M Whang, S I Park, I A Trenary, et al.
Lung Cancer (Amsterdam, Netherlands)|March 26, 2020
Prognostic value and therapeutic implications of expanded molecular testing for resected early stage lung adenocarcinomaPeter J Kneuertz, David P Carbone, Desmond M D'Souza, et al.
Lung Cancer (Amsterdam, Netherlands)|April 5, 2016
Epidermal growth factor receptor (EGFR) mutations in small cell lung cancers: Two cases and a review of the literatureBradford J Siegele, Konstantin Shilo, Bo H Chao, et al.
JTO Clinical and Research Reports|October 14, 2021
Comparison of Tumor Microenvironments Between Primary Tumors and Brain Metastases in Patients With NSCLCDaiki Ikarashi, Tamio Okimoto, Takehito Shukuya, et al.
Cancer Research|September 18, 2004
Combination therapy with conditionally replicating adenovirus and replication defective adenovirusChoon-Taek Lee, Kyung-Ho Park, Kiyoshi Yanagisawa, et al.
Lung Cancer (Amsterdam, Netherlands)|October 27, 2019
Cost-effectiveness analysis of pembrolizumab versus chemotherapy as first-line treatment in locally advanced or metastatic non-small cell lung cancer with PD-L1 tumor proportion score 1% or greaterLongjiang She, Huabin Hu, Mengting Liao, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 13, 2001
Phase I chemoprevention study of difluoromethylornithine in subjects with organ transplantsP P Carbone, J D Pirsch, J P Thomas, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 28, 2017
Prognostic Value of Primary Tumor Volume Changes on kV-CBCT during Definitive Chemoradiotherapy for Stage III Non-Small Cell Lung CancerPatrick Wald, Xiaokui Mo, Christian Barney, et al.
Pageof 66